Related Experiment Video
Updated: Feb 11, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy
Yangjin Kim1,2, Ji Young Yoo3, Tae Jin Lee3
1Mathematical Biosciences Institute, The Ohio State University, Columbus, OH 43210.
Abstract:
In the present work, we investigated the role of natural killer (NK) cells in combination therapy with oncolytic virus (OV) and bortezomib, a proteasome inhibitor. NK cells display rapid and potent immunity to metastatic and hematological cancers, and they overcome immunosuppressive effects of tumor microenvironment. We developed a mathematical model to address the question of how the density of NK cells affects the growth of the tumor. We found that the antitumor efficacy increases when the endogenous NKs are depleted and also when exogenous NK cells are injected into the tumor. These predictions were validated by our in vivo and in vitro experiments.
Insights
This study reveals that natural killer (NK) cells enhance cancer treatment efficacy. Depleting or injecting NK cells boosts the effectiveness of oncolytic virus and bortezomib combination therapy against tumors.
Area of Science:
- Immunology
- Cancer Biology
- Mathematical Modeling
Background:
- Natural killer (NK) cells are crucial for cancer immunity, combating both metastatic and hematological cancers.
- NK cells can overcome the immunosuppressive tumor microenvironment.
- Oncolytic viruses (OVs) and bortezomib are emerging cancer therapeutics.
Purpose of the Study:
- To investigate the role of NK cells in combination therapy with OVs and bortezomib.
- To determine how NK cell density impacts tumor growth.
- To model the interplay between NK cells, OVs, and bortezomib in cancer treatment.
Main Methods:
- Development of a mathematical model to simulate NK cell density and tumor growth.
- In vitro experiments to assess therapeutic effects.
- In vivo experiments to validate model predictions.
Main Results:
- Mathematical model predicted increased antitumor efficacy with NK cell modulation.
- Both depletion of endogenous NK cells and injection of exogenous NK cells enhanced treatment outcomes.
- Experimental validation confirmed the model's predictions regarding NK cell roles.
Conclusions:
- NK cell density is a critical factor in the efficacy of combined OV and bortezomib cancer therapy.
- Modulating NK cell populations (depletion or augmentation) can significantly improve antitumor responses.
- This research provides a foundation for optimizing NK cell-based combination cancer treatments.
Related Concept Videos
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Gene Therapy
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
What are Viruses?

